Skip directly to Accessibility Notice

Bionic is a portmanteau from biology and electronics and is often confused with the word “Cyborg,” which describes a being with organic and mechatronic body parts. Bionics, or biologically inspired engineering, is the application of concepts and systems found in nature to design systems and products. With advancements in physiotherapy, robotics and medicine, bionic engineering is poised to find applications in healthcare.

Source: Wikipedia.

VanEck Bionic Engineering UCITS ETF

  • Bionic ETF invests in global leaders in healthcare trends
  • Companies involved in groundbreaking healthcare technology solutions for the most complex and challenging conditions
  • An impact ETF
  • 0.55% total expense ratio

ETF Details

ETF Details

Basis-Ticker: CYBO
ISIN: IE0005TF96I9
TER: 0.55%
AUM: $5.4M
SFDR Classification: Article 9


Lower risk

Typically lower reward

Higher risk

Typically higher reward

Risks of a Bionic ETF: You may lose money up to the total loss of your investment due to the Main Risk Factors, such as Industry or Sector Concentration Risk and Liquidity Risks described below in the KID and the sales prospectus. Evolving of the market is not guaranteed.

Experts anticipate there are four stages to the biomachine interface evolution.1 Below are some examples:

1 Source: McKinsey Global Institute.

Brain stimulation for Parkinson’s, neuroprosthetics for hearing, to brain activity monitoring to diagnose diseases.

Neuroprosthetics for sight, deep brain stimulation for Alzheimer’s, depression, and anxiety, to neuro priming for athletic performance.

From neuroergonomics to improve workplace design (e.g., reduce stress levels in the cockpit); to direct brain-to-device communication for paralyzed people.

From interpreting emotions through measured brain waves and enhancing sensory perception for consumer use to leveraging computers to augment the brain.

Why Invest in a Bionic ETF?

Bionics is a fast-expanding medical field set to fulfill a substantial need. Our Bionic ETF offers one of the few ways to invest in a diversified portfolio of companies.

Helping the Ageing Population

Source: UN population prospects.

Companies in this ETF

Today the companies underlying the Bionic ETF specialize in a range of fields, from heart valves to medical implants and diabetes monitoring devices. They include Edwards Lifesciences, a leader in artificial heart valves; Medtronic, which makes insulin pumps and pacemakers; and Stryker Corp, known for its joint replacements. As the new interfaces between man and machine evolve, so will the ETF’s holdings.

Main Risk Factors of Bionic ETF


It exists when a particular financial instrument is difficult to purchase or sell. If the relevant market is illiquid, it may not be possible to initiate a transaction or liquidate a position at an advantageous or reasonable price or at all.


The prices of the securities in the Fund are subject to the risks associated with investing in the securities market, including general economic conditions and sudden and unpredictable drops in value. An investment in Bionic ETF may lose money.


The Fund’s assets may be concentrated in one or more particular sectors or industries. Bionic ETF may be subject to the risk that economic, political or other conditions that have a negative effect on the relevant sectors or industries will negatively impact the Fund's performance to a greater extent than if the Fund’s assets were invested in a wider variety of sectors or industries.